Seeking Alpha

Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance...

Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance presentation. The company sees Q4 earnings in the mid-range of estimates, while it ups 2012 EPS estimates to between $3.95 - $4.20. More importantly, the company says there's still no agreement on the buyout process or price with Ista Pharmaceuticals (ISTA -0.4%), following Ista's rejection of its recent bid in December, and puts a drop dead date of January 31 for negotiations.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|